TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
about
Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor.Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens.Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity.Improving T cell responses to modified peptides in tumor vaccinesSarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8+ T-cell Recognition of a Retroviral Antigen.Mimotope vaccine efficacy gets a "boost" from native tumor antigensCIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients.
P2860
Q35012363-84C576C0-22F2-4BA5-9313-E18E87986D7BQ35498335-9D230F18-0E5E-4033-886C-67D2D0092962Q36510860-37B5E2BB-E647-4B3A-93FB-660B0061313EQ37494158-8C0A2A8B-0CA6-480D-AAEE-ED5959796874Q37634253-063ACE67-8B84-44A4-A474-EB4EA302518AQ38704265-98590F42-BB7C-403E-90F4-AFA48C3F96DDQ40725023-05FFF309-3B0C-4C5A-B807-65ADB82E33DFQ42723974-9BD7CDD1-B700-4FEB-9A18-20C74E6C6C42Q47405972-20804316-7494-4EDB-A4D0-E796DC3B859DQ52757687-9636AFCC-749E-4A2C-BD95-72DD60B33295
P2860
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
@ast
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
@en
type
label
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
@ast
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
@en
prefLabel
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
@ast
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
@en
P2093
P2860
P1476
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
@en
P2093
Brandon L Moore
Dexiang Gao
Jill E Slansky
Jonathan D Buhrman
Jonathan Sprague
Kimberly R Jordan
P2860
P2888
P304
P356
10.1007/S00262-012-1217-5
P50
P577
2012-02-21T00:00:00Z